Oncare raises INR 27 Crore in Series A led by Sky Impact Capital

Oncare, a rapidly scaling oncology care platform focused on delivering standardised and affordable cancer treatment through a distributed, capital-efficient model, has raised USD 4 million in Series A funding led by Sky Impact Capital. The investment reinforces Sky’s mission to improve access to quality healthcare nationwide, leveraging its experience in building scaled, single-specialty healthcare platforms, following its partnership in the growth of ASG Eye Hospitals into one of India’s largest eyecare networks. The round also saw participation from Huddle Ventures, Lotus Herbal Group, SteerX, and Tremis Capital.

The fresh capital will be used to expand into new metro markets as well as Tier-2 and Tier-3 cities. It will also support deeper investments in technology infrastructure to streamline clinical operations, strengthen care coordination, and create a more seamless, patient-centric treatment journey.

Oncare operates in India’s fast-growing oncology care market, which is projected to reach INR 43,000 crore by FY28, growing at an estimated ~14% CAGR. Yet access to quality cancer treatment remains uneven. Much of the country’s capacity is tied to asset-heavy hospital infrastructure that is slow to scale and expensive to replicate.

Oncare is addressing this structural gap through a capital-efficient oncology model. The platform integrates medical, surgical, and radiation oncology within accredited hospitals while maintaining strong clinical governance, insurance integration, and transparent pricing. This approach enables faster expansion without compromising affordability or quality of care.

Deepak Kumar, Co-founder of Oncare, said, “A cancer diagnosis is overwhelming enough. Access to the right care should not make it harder. Our goal with Oncare is to make high-quality treatment more reachable, more transparent, and more humane for families across India. With this support, we are taking an important step toward building a nationwide network that delivers trusted oncology care closer to home.”

“India’s oncology challenge cannot be solved by infrastructure alone, it requires operating systems that scale quality, affordability and trust together. Oncare represents this next-generation approach, and we believe the platform has all the right ingredients. We look forward to partnering closely with Amar Sneh and Deepak Kumar, and to applying Sky’s proven single-specialty healthcare playbook to create meaningful impact for patients across India,” said Aakash Sachdev, Founder, Sky Impact Capital.

Since its launch in 2023, Oncare has quickly evolved into a multi-centre oncology platform across Delhi NCR. The company has built clinical credibility, growing patient trust and consistent operating momentum within a short span of time.

With this investment, Oncare aims to scale into a nationally distributed oncology platform that combines clinical excellence, affordability, and operational efficiency. Its long-term vision is to redefine how cancer care is delivered across emerging healthcare markets in India, bringing quality treatment closer to where patients live.